China IVD Market and Forecast to 2020
China In-Vitro Diagnostics (IVD) market is among the fastest growing in the world. It is anticipated that China IVD market will more than triple by 2020 from the 2014 level. With an aging population, a rapidly growing middle class and a government encouraging preventive care, China has the potential for more dramatic growth in the future. Further, the average Chinese consumer is now willing and able to pay more for healthcare than a decade years ago. Hence, China has the potential for more dramatic growth in the future.
China IVD Market Segment Wise Analysis: Immunoassay is the leading segment in China IVD market. Immunoassay is likely to maintain its dominant position in the forecasting period as well. Clinical Chemistry holds the 2nd position in China IVD market being followed by Molecular Testing. SMBG market accounted for XXX percent market share in 2014. Microbiology and Hematology market are competing closely with XXX percent and XXX percent market share respectively in 2014.
China IVD Market Company Analysis: In China IVD market, Roche Diagnostics is the leader with XXX percent market share in 2014. Sysmex Corporation and Mindary Medical are other top two players in the China IVD market. At present many local players are present in China IVD market and their combined market share was XXX percent in 2014.
iGATE RESEARCH report titled “China IVD Market and Forecast to 2020” is a 86 page report with 34 Figures and 1 Table. This report studies in details the China IVD Market - Application Segment Wise, China IVD Market - Company Sales, Development Environment and Regulatory Status in China IVD market and Driving Factors and Challenges for China IVD Market.
The China In Vitro Diagnostics (IVD) Market has been analyzed from 4 View Points:
1) Market and Forecast (2007 - 2020)
2) Segment Wise Market & Forecast (2007 - 2020)
3) Development Environment and Regulatory Status in China IVD market
4) Company Wise IVD Sales & Forecast (2010 - 2020)
China IVD Market - 8 Application Segments Covered in the Report are:
1. Clinical Chemistry Market
2. Immunoassay Market
3. Hematology Market
4. Coagulation Market
5. Microbiology Market
6. Molecular Testing Market
7. Self Monitoring of Blood Glucose (SMBG) Market
8. Point of Care Testing (POCT) Market
The Companies covered in the report are as follows:
iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.
Research Methodologies
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government And NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries And Local Councils and a large number of Paid Databases.
China IVD Market Segment Wise Analysis: Immunoassay is the leading segment in China IVD market. Immunoassay is likely to maintain its dominant position in the forecasting period as well. Clinical Chemistry holds the 2nd position in China IVD market being followed by Molecular Testing. SMBG market accounted for XXX percent market share in 2014. Microbiology and Hematology market are competing closely with XXX percent and XXX percent market share respectively in 2014.
China IVD Market Company Analysis: In China IVD market, Roche Diagnostics is the leader with XXX percent market share in 2014. Sysmex Corporation and Mindary Medical are other top two players in the China IVD market. At present many local players are present in China IVD market and their combined market share was XXX percent in 2014.
iGATE RESEARCH report titled “China IVD Market and Forecast to 2020” is a 86 page report with 34 Figures and 1 Table. This report studies in details the China IVD Market - Application Segment Wise, China IVD Market - Company Sales, Development Environment and Regulatory Status in China IVD market and Driving Factors and Challenges for China IVD Market.
The China In Vitro Diagnostics (IVD) Market has been analyzed from 4 View Points:
1) Market and Forecast (2007 - 2020)
2) Segment Wise Market & Forecast (2007 - 2020)
3) Development Environment and Regulatory Status in China IVD market
4) Company Wise IVD Sales & Forecast (2010 - 2020)
China IVD Market - 8 Application Segments Covered in the Report are:
1. Clinical Chemistry Market
2. Immunoassay Market
3. Hematology Market
4. Coagulation Market
5. Microbiology Market
6. Molecular Testing Market
7. Self Monitoring of Blood Glucose (SMBG) Market
8. Point of Care Testing (POCT) Market
The Companies covered in the report are as follows:
- Roche Diagnostic
- Sysmex Corporation
- Mindray Medical International Limited
- Shanghai Kehua Bio-Engineering Co. Ltd.
- Others
- Zhejiang Di’an Diagnostics Technology Co., Ltd
- ADICON Clinical Laboratories
- Guangzhou Kingmed Diagnostics Center Co. Ltd.
- Kindstar Global (Privately held)
- BGI-Shenzhen (Privately held)
- OriGene Technologies (Privately held)
iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.
Research Methodologies
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government And NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries And Local Councils and a large number of Paid Databases.
1. EXECUTIVE SUMMARY
2. CHINA IVD MARKET AND MARKET SHARE ANALYSIS (2007 - 2020)
2.1 China IVD Market and Forecast
2.2 China IVD Market Share and Forecast
2.3 China IVD Company Share and Forecast
3. CHINA IVD - SEGMENTS WISE MARKET AND FORECAST (2007 - 2020)
3.1 China Clinical Chemistry Market and Forecast
3.2 China Immunoassay Market and Forecast
3.3 China Hematology Market and Forecast
3.4 China Coagulation Market and Forecast
3.5 China Microbiology Market and Forecast
3.6 China Molecular Testing Market and Forecast
3.7 China Self Monitoring of Blood Glucose (SMBG) Market and Forecast
3.8 China Point of Care Testing (POCT) Market and Forecast
4. DEVELOPMENT ENVIRONMENT OF CHINESE IVD INDUSTRY
4.1 State Healthcare Reforms
4.2 State Citizen-Benefiting Policies
4.3 Requirements of Hospital Upgrading
5. PROFILE OF IN-VITRO DIAGNOSTIC REAGENTS REGISTRATION CONTROL
5.1 Regulatory History in China IVD Market
5.2 Regulatory Status in China IVD Market
5.2.1 Blood Screening Reagents - Drug Administration
5.2.2 Varieties of Blood Screening Reagents
5.2.3 Blood Screening Reagent Test
5.2.4 Nucleic Acid Detection Kits for Blood Screening
5.2.5 Radioactive reagents - Drug Administration
5.2.6 Diagnostic Reagents - Medical Devices Management
5.3 Regulatory Trend in China IVD Market
5.3.1 Blood Screening Reagents Belonging
5.3.2 Quality Improvement
5.3.3 Pre-Evaluation of Registration Standards
6. CHINA IVD MARKET - COMPANY WISE SALES ANALYSIS (2010 - 2020)
6.1 Roche Diagnostic - China IVD Sales and Forecast
6.2 Sysmex Corporation - China IVD Sales and Forecast
6.3 Mindray Medical International Limited - China IVD Sales and Forecast
6.4 Shanghai Kehua Bio-Engineering Co. Ltd. - China IVD Sales & Forecast
6.5 Others - China IVD Sales and Forecast
7. PROFILES OF SELECT PRIVATE CLINICAL LABS AND DIAGNOSTIC SERVICES COMPANIES
7.1 Zhejiang Di’an Diagnostics Technology Co., Ltd.
7.1.1 Company Overview
7.1.2 Products and Services Offered by Di’an
7.2 ADICON Clinical Laboratories (Privately held)
7.2.1 Company Overview
7.2.2 Products and Services Offered by ADICON
7.3 Guangzhou Kingmed Diagnostics Center Co. Ltd.
7.3.1 Company Overview
7.3.2 Products and Services Offered by Kingmed
7.4 Kindstar Global (Privately held)
7.4.1 Company Overview
7.4.2 Products and Services Offered by Kindstar
7.5 BGI-Shenzhen
7.5.1 Company Overview
7.5.2 BGI’s Innovative Approach
7.6 OriGene Technologies
7.6.1 Company Overview
7.6.2 Products and Services Offered by OriGene
8. CHINA IVD INDUSTRY DRIVERS
8.1 Government Efforts to Regulate Laboratory Testing
8.2 Increasing Number of Private Hospitals & Independent Testing Laboratories
8.3 Chinese Government Policies Encourage Investment in IVD
9. CHINA IVD INDUSTRY CHALLENGE
9.1 Lack of Expertise in Advanced Technology in the Local Companies
9.2 Price Pressures Limits the Participation of Multinational IVD Companies in the China IVD Market
9.3 Reimbursement Rates of Different Products Varies in Different Provinces
LIST OF FIGURE:
Figure 2 1: China - IVD Market (Million US$), 2007 - 2014
Figure 2 2: China - Forecast for IVD Market (Million US$), 2015 - 2020
Figure 2 3: China - IVD Market Share (Percent), 2007 - 2014
Figure 2 4: China - Forecast for IVD Market Share (Percent), 2015 - 2020
Figure 2 5: China IVD Market - Company Share (Percent), 2010 - 2014
Figure 2 6: China IVD Market - Forecast for Company Share (Percent), 2015 - 2020
Figure 3 1: China - Clinical Chemistry Market (Million US$), 2007 - 2014
Figure 3 2: China - Forecast for Clinical Chemistry Market (Million US$), 2015 - 2020
Figure 3 3: China - Immunoassay Market (Million US$), 2007 - 2014
Figure 3 4: China - Forecast for Immunoassay Market (Million US$), 2015 - 2020
Figure 3 5: China - Hematology Market (Million US$), 2007 - 2014
Figure 3 6: China - Forecast for Hematology Market (Million US$), 2015 - 2020
Figure 3 7: China - Coagulation Market (Million US$), 2007 - 2014
Figure 3 8: China - Forecast for Coagulation Market (Million US$), 2015 - 2020
Figure 3 9: China - Microbiology Market (Million US$), 2007 - 2014
Figure 3 10: China - Forecast for Microbiology Market (Million US$), 2015 - 2020
Figure 3 11: China - Molecular Testing Market (Million US$), 2007 - 2014
Figure 3 12: China - Forecast for Molecular Testing Market (Million US$), 2015 - 2020
Figure 3 13: China - SMBG Market (Million US$), 2007 - 2014
Figure 3 14: China - Forecast for SMBG Market (Million US$), 2015 - 2020
Figure 3 15: China - POCT Market (Million US$), 2007 - 2014
Figure 3 16: China - Forecast for POCT Market (Million US$), 2015 - 2020
Figure 6 1: Roche Diagnostic - China IVD Revenue (Million US$), 2010-2014
Figure 6 2: Roche Diagnostic - Forecast for China IVD Revenue (Million US$), 2015 - 2020
Figure 6 3: Sysmex Corporation - China IVD Revenue (Million US$), 2010 - 2014
Figure 6 4: Sysmex Corporation - Forecast for China IVD Revenue (Million US$), 2015 - 2020
Figure 6 5: Mindray Medical - China IVD Revenue (Million US$), 2010 - 2014
Figure 6 6: Mindray Medical - Forecast for China IVD Revenue (Million US$), 2015 - 2020
Figure 6 7: Shanghai Kehua - China IVD Revenue (Million US$), 2010 - 2014
Figure 6 8: Shanghai Kehua - Forecast for China IVD Revenue (Million US$), 2015 - 2020
Figure 6 9: Others - China IVD Revenue (Million US$), 2010 - 2014
Figure 6 10: Others - Forecast for China IVD Revenue (Million US$), 2015 - 2020
Figure 7 1: Kindstar - Collaboration with Hospitals in China (Number), 2006 - 2012
Figure 8 1: China - Healthcare Spending (Billion US$), 2011 and 2020
2. CHINA IVD MARKET AND MARKET SHARE ANALYSIS (2007 - 2020)
2.1 China IVD Market and Forecast
2.2 China IVD Market Share and Forecast
2.3 China IVD Company Share and Forecast
3. CHINA IVD - SEGMENTS WISE MARKET AND FORECAST (2007 - 2020)
3.1 China Clinical Chemistry Market and Forecast
3.2 China Immunoassay Market and Forecast
3.3 China Hematology Market and Forecast
3.4 China Coagulation Market and Forecast
3.5 China Microbiology Market and Forecast
3.6 China Molecular Testing Market and Forecast
3.7 China Self Monitoring of Blood Glucose (SMBG) Market and Forecast
3.8 China Point of Care Testing (POCT) Market and Forecast
4. DEVELOPMENT ENVIRONMENT OF CHINESE IVD INDUSTRY
4.1 State Healthcare Reforms
4.2 State Citizen-Benefiting Policies
4.3 Requirements of Hospital Upgrading
5. PROFILE OF IN-VITRO DIAGNOSTIC REAGENTS REGISTRATION CONTROL
5.1 Regulatory History in China IVD Market
5.2 Regulatory Status in China IVD Market
5.2.1 Blood Screening Reagents - Drug Administration
5.2.2 Varieties of Blood Screening Reagents
5.2.3 Blood Screening Reagent Test
5.2.4 Nucleic Acid Detection Kits for Blood Screening
5.2.5 Radioactive reagents - Drug Administration
5.2.6 Diagnostic Reagents - Medical Devices Management
5.3 Regulatory Trend in China IVD Market
5.3.1 Blood Screening Reagents Belonging
5.3.2 Quality Improvement
5.3.3 Pre-Evaluation of Registration Standards
6. CHINA IVD MARKET - COMPANY WISE SALES ANALYSIS (2010 - 2020)
6.1 Roche Diagnostic - China IVD Sales and Forecast
6.2 Sysmex Corporation - China IVD Sales and Forecast
6.3 Mindray Medical International Limited - China IVD Sales and Forecast
6.4 Shanghai Kehua Bio-Engineering Co. Ltd. - China IVD Sales & Forecast
6.5 Others - China IVD Sales and Forecast
7. PROFILES OF SELECT PRIVATE CLINICAL LABS AND DIAGNOSTIC SERVICES COMPANIES
7.1 Zhejiang Di’an Diagnostics Technology Co., Ltd.
7.1.1 Company Overview
7.1.2 Products and Services Offered by Di’an
7.2 ADICON Clinical Laboratories (Privately held)
7.2.1 Company Overview
7.2.2 Products and Services Offered by ADICON
7.3 Guangzhou Kingmed Diagnostics Center Co. Ltd.
7.3.1 Company Overview
7.3.2 Products and Services Offered by Kingmed
7.4 Kindstar Global (Privately held)
7.4.1 Company Overview
7.4.2 Products and Services Offered by Kindstar
7.5 BGI-Shenzhen
7.5.1 Company Overview
7.5.2 BGI’s Innovative Approach
7.6 OriGene Technologies
7.6.1 Company Overview
7.6.2 Products and Services Offered by OriGene
8. CHINA IVD INDUSTRY DRIVERS
8.1 Government Efforts to Regulate Laboratory Testing
8.2 Increasing Number of Private Hospitals & Independent Testing Laboratories
8.3 Chinese Government Policies Encourage Investment in IVD
9. CHINA IVD INDUSTRY CHALLENGE
9.1 Lack of Expertise in Advanced Technology in the Local Companies
9.2 Price Pressures Limits the Participation of Multinational IVD Companies in the China IVD Market
9.3 Reimbursement Rates of Different Products Varies in Different Provinces
LIST OF FIGURE:
Figure 2 1: China - IVD Market (Million US$), 2007 - 2014
Figure 2 2: China - Forecast for IVD Market (Million US$), 2015 - 2020
Figure 2 3: China - IVD Market Share (Percent), 2007 - 2014
Figure 2 4: China - Forecast for IVD Market Share (Percent), 2015 - 2020
Figure 2 5: China IVD Market - Company Share (Percent), 2010 - 2014
Figure 2 6: China IVD Market - Forecast for Company Share (Percent), 2015 - 2020
Figure 3 1: China - Clinical Chemistry Market (Million US$), 2007 - 2014
Figure 3 2: China - Forecast for Clinical Chemistry Market (Million US$), 2015 - 2020
Figure 3 3: China - Immunoassay Market (Million US$), 2007 - 2014
Figure 3 4: China - Forecast for Immunoassay Market (Million US$), 2015 - 2020
Figure 3 5: China - Hematology Market (Million US$), 2007 - 2014
Figure 3 6: China - Forecast for Hematology Market (Million US$), 2015 - 2020
Figure 3 7: China - Coagulation Market (Million US$), 2007 - 2014
Figure 3 8: China - Forecast for Coagulation Market (Million US$), 2015 - 2020
Figure 3 9: China - Microbiology Market (Million US$), 2007 - 2014
Figure 3 10: China - Forecast for Microbiology Market (Million US$), 2015 - 2020
Figure 3 11: China - Molecular Testing Market (Million US$), 2007 - 2014
Figure 3 12: China - Forecast for Molecular Testing Market (Million US$), 2015 - 2020
Figure 3 13: China - SMBG Market (Million US$), 2007 - 2014
Figure 3 14: China - Forecast for SMBG Market (Million US$), 2015 - 2020
Figure 3 15: China - POCT Market (Million US$), 2007 - 2014
Figure 3 16: China - Forecast for POCT Market (Million US$), 2015 - 2020
Figure 6 1: Roche Diagnostic - China IVD Revenue (Million US$), 2010-2014
Figure 6 2: Roche Diagnostic - Forecast for China IVD Revenue (Million US$), 2015 - 2020
Figure 6 3: Sysmex Corporation - China IVD Revenue (Million US$), 2010 - 2014
Figure 6 4: Sysmex Corporation - Forecast for China IVD Revenue (Million US$), 2015 - 2020
Figure 6 5: Mindray Medical - China IVD Revenue (Million US$), 2010 - 2014
Figure 6 6: Mindray Medical - Forecast for China IVD Revenue (Million US$), 2015 - 2020
Figure 6 7: Shanghai Kehua - China IVD Revenue (Million US$), 2010 - 2014
Figure 6 8: Shanghai Kehua - Forecast for China IVD Revenue (Million US$), 2015 - 2020
Figure 6 9: Others - China IVD Revenue (Million US$), 2010 - 2014
Figure 6 10: Others - Forecast for China IVD Revenue (Million US$), 2015 - 2020
Figure 7 1: Kindstar - Collaboration with Hospitals in China (Number), 2006 - 2012
Figure 8 1: China - Healthcare Spending (Billion US$), 2011 and 2020
LIST OF TABLES:
Table 8 1: China Food and Drug Administration - Regulation and Impact for Medical Device and IVD Manufacturers Selling in China
Table 8 1: China Food and Drug Administration - Regulation and Impact for Medical Device and IVD Manufacturers Selling in China
